These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22887716)

  • 1. E2F3b over-expression in ovarian carcinomas and in BRCA1 haploinsufficient fallopian tube epithelium.
    Smith NL; Welcsh P; Press JZ; Agnew KJ; Garcia R; Swisher EM
    Genes Chromosomes Cancer; 2012 Nov; 51(11):1054-62. PubMed ID: 22887716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.
    Press JZ; Wurz K; Norquist BM; Lee MK; Pennil C; Garcia R; Welcsh P; Goff BA; Swisher EM
    Neoplasia; 2010 Dec; 12(12):993-1002. PubMed ID: 21170264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.
    Norquist BM; Garcia RL; Allison KH; Jokinen CH; Kernochan LE; Pizzi CC; Barrow BJ; Goff BA; Swisher EM
    Cancer; 2010 Nov; 116(22):5261-71. PubMed ID: 20665887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status.
    George SH; Milea A; Shaw PA
    Clin Cancer Res; 2012 Nov; 18(22):6199-207. PubMed ID: 22967960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
    Staff S; Tolonen T; Laasanen SL; Mecklin JP; Isola J; Mäenpää J
    Int J Gynecol Pathol; 2014 May; 33(3):309-16. PubMed ID: 24681744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.
    Danielian PS; Friesenhahn LB; Faust AM; West JC; Caron AM; Bronson RT; Lees JA
    Oncogene; 2008 Nov; 27(51):6561-70. PubMed ID: 18663357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.
    Pennington KP; Wickramanayake A; Norquist BM; Pennil CC; Garcia RL; Agnew KJ; Taniguchi T; Welcsh P; Swisher EM
    Gynecol Oncol; 2013 Mar; 128(3):493-9. PubMed ID: 23246380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.
    Tone AA; Begley H; Sharma M; Murphy J; Rosen B; Brown TJ; Shaw PA
    Clin Cancer Res; 2008 Jul; 14(13):4067-78. PubMed ID: 18593983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.
    Yucer N; Ahdoot R; Workman MJ; Laperle AH; Recouvreux MS; Kurowski K; Naboulsi DJ; Liang V; Qu Y; Plummer JT; Gayther SA; Orsulic S; Karlan BY; Svendsen CN
    Cell Rep; 2021 Dec; 37(13):110146. PubMed ID: 34965417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1/DAB2 axis.
    Tone AA; Virtanen C; Shaw P; Brown TJ
    Clin Cancer Res; 2012 Aug; 18(16):4334-44. PubMed ID: 22753593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development.
    Chong JL; Tsai SY; Sharma N; Opavsky R; Price R; Wu L; Fernandez SA; Leone G
    Mol Cell Biol; 2009 Jan; 29(2):414-24. PubMed ID: 19015245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.
    Press JZ; De Luca A; Boyd N; Young S; Troussard A; Ridge Y; Kaurah P; Kalloger SE; Blood KA; Smith M; Spellman PT; Wang Y; Miller DM; Horsman D; Faham M; Gilks CB; Gray J; Huntsman DG
    BMC Cancer; 2008 Jan; 8():17. PubMed ID: 18208621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis.
    George SH; Milea A; Sowamber R; Chehade R; Tone A; Shaw PA
    Oncogene; 2016 Jan; 35(1):59-68. PubMed ID: 25798842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma.
    Tone AA; Virtanen C; Shaw PA; Brown TJ
    Endocr Relat Cancer; 2011 Apr; 18(2):221-34. PubMed ID: 21263043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution.
    Bartlett TE; Chindera K; McDermott J; Breeze CE; Cooke WR; Jones A; Reisel D; Karegodar ST; Arora R; Beck S; Menon U; Dubeau L; Widschwendter M
    Nat Commun; 2016 May; 7():11620. PubMed ID: 27216078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial Cells.
    Hollingsworth J; Lau A; Tone A; Kollara A; Allen L; Colgan TJ; Dube V; Rosen B; Murphy KJ; Greenblatt EM; Feigenberg T; Virtanen C; Brown TJ
    Neoplasia; 2018 Jul; 20(7):697-709. PubMed ID: 29852322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
    Piek JM; Dorsman JC; Massuger LF; Ansink AC; Weegenaar J; Shvarts A; Kenemans P; Verheijen RH
    Arch Gynecol Obstet; 2006 Oct; 274(6):327-31. PubMed ID: 16826413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors.
    McGonigal S; Wu R; Grimley E; Turk EG; Zhai Y; Cho KR; Buckanovich RJ
    Gynecol Oncol; 2023 Sep; 176():139-146. PubMed ID: 37535994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan.
    Munakata S; Yamamoto T
    Int J Gynecol Pathol; 2015 Jan; 34(1):9-18. PubMed ID: 25473747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers.
    Bijron JG; van der Groep P; van Dorst EB; Seeber LM; Sie-Go DM; Verheijen RH; van Diest PJ
    Endocr Relat Cancer; 2012 Feb; 19(1):69-81. PubMed ID: 22143498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.